Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients

Ibiloye, E.; Barner, Jamie C.; Lawson, Kenneth A.; Rascati, Karen L.; Evoy, Kirk E.; Peckham, Alyssa M.

doi:10.1007/s40261-021-01009-6

Cited by 8 publications

(2 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The strong public health concern about the increasing use of gabapentinoids [38–42] was not mirrored in communities' views through tweets. Content about unintended included tweets mentioning online (internet) ordering and euphoric properties.…”

Section: Discussionmentioning

confidence: 99%

“…Despite our sentiment analysis uncovering more negative than positive comments towards gabapentinoids, the thematic analysis revealed supportive and sympathetic content that potentially provided reassurance to those online members. The strong public health concern about the increasing use of gabapentinoids [38][39][40][41][42] was not mirrored in communities' views through tweets. Content about unintended included tweets mentioning online (internet) ordering and euphoric properties.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Content and sentiment analysis of gabapentinoid‐related tweets: An infodemiology study

Mathieson

O’Keeffe

Traeger

et al. 2022

Drug and Alcohol Review

View full text Add to dashboard Cite

IntroductionThe increasing number of gabapentinoid (pregabalin and gabapentin) harms, including deaths observed across countries is concerning to health‐care professionals and policy makers. However, it is unclear if the public shares these concerns. This study aimed to describe posts related to gabapentinoids, conduct a content analysis to identify common themes and describe adverse events or symptoms.MethodsKeywords of ‘pregabalin’ or ‘Lyrica’ or ‘gabapentin’ or ‘Neurontin’ were used to search for related tweets posted by people in the community between 8 March and 7 May 2021. Eligible tweets included a keyword in the post. We extracted de‐identified data which included descriptive data of the total number of posts over time; and data on individual tweets including date, number of re‐tweets and post content. Data were exported separately for pregabalin‐ and gabapentin‐related tweets. A 20% random sample was used for the thematic analysis.ResultsThere were 2931 pregabalin‐related tweets and 2736 gabapentin‐related tweets. Thematic analysis revealed three themes (sharing positive experiences and benefits of taking gabapentinoids, people voicing their negative experiences, and people seeking opinions and sharing information). Positive experiences of gabapentinoids were related to sharing stories and giving advice. This was contrasted to negative experiences including ineffectiveness, withdrawals, side effects and frustration related to cost and insurance coverage. Brain fog was the most common adverse symptom reported. Gabapentinoid‐related deaths were only mentioned in three tweets.DiscussionThe increasing public health concern of gabapentinoid‐related deaths was not translated to Twitter discussions.

show abstract

Section: Discussionmentioning

confidence: 99%